Biotechnology
Biotechnology the Market to Watch: The Top Two Percent Gainers on Nasdaq Today
Biotechnology was the winner today on the Nasdaq exchange, with two biotech companies ranking as number one and two for the top percentage gainers for the day. Neuralstem, Inc. Neuralstem, Inc. (NASDAQ:CUR) is a biotech ... [Read]
Biotechnology
Midatech Pharma Closes At 75% Over Previous Close – Will the Stock Continue to Rise?
Midatech Pharma Plc (NASDAQ:MTP) closed on Tuesday’s market at $1.47, which was up $0.63, or 75%, from the previous closing price of $0.84, giving the company its first stock hike since November 2017. The company ... [Read]
Biotechnology
Ignyta Inc. Investigation Continues
When Ignyta Inc. (NASDAQ:RXDX) was bought by Roche Holding Ltc (OTCQX:RHHBF), the December 22 news brought on a huge spike in Ignyta’s stock price, which went from $15.55 to $26.85 that day. But it also ... [Read]
Biotechnology
BrainStorm Cell Therapeutics Stock Up Almost 30% After Company Sends Out Positive Letter to Shareholders
Considering today is the last trading day of the year, and BrainStorm Cell Therapeutics Inc. (NASDAQ:BCLI) is one of the market’s trending tickers of the day, I think it’s safe to say that the New ... [Read]
Biotechnology
Atara Biotherapeutics Gets FDA Approval and Stock Climbs Over 20%
Atara Biotherapeutics, Inc. (NASDAQ:ATRA) has been having a good day today! The stock peaked this morning at $21.80 and has since leveled off a bit. Currently, the stock is trading at $18.55, putting it up ... [Read]
Biotechnology
Is vTv Therapeutics Making a Comeback? Stock up Almost 40% Despite Plunging on Dec. 25
The general consensus surrounding stocks and the market is that it can be an extremely volatile environment, and it seems that vTv Therapeutics, Inc. (NASDAQ:VTVT) is living up to that reputation, and it is important ... [Read]
Biotechnology
Auris Medical Holding to Provide Update on Development Program with AM-111, Stock Jumps Almost 30%
The market may have just started to pick up its stride, but Auris Medical Holding AG (NASDAQ:EARS) has already grabbed the attention of a number of investors as it is up, as of this writing, ... [Read]
Biotechnology
Why is Ignyta, Inc. Under Investigation After Signing Deal with Roche Holding?
Ignyta, Inc. (NASDAQ:RXDX) stock has surged today on the news of its buyout from big-time cancer research company Roche Holding Ltc (OTCQX:RHHBF). While everything started off smoothly on this deal, suspicions have arisen that Ignyta’s ... [Read]
Biotechnology
Q BioMed Inc. Shares Up 10%, As Company Announces Big Movements In 2018 With Cancer Aid Drug
The New York-based Biotech accelerator, Q BioMed Inc. (OTCQB:QBIO) saw its shares rise 10.96%, to $4.05 each. Of its latest four projects in the works, the most ‘revenue ready’ is the Strontium Chloride 89 (SR89) ... [Read]
Biotechnology
Corcept Therapeutics Joins the S&P SmallCap 600, Stock Rises 11%
Corcept Therapeutics Incorporated (NASDAQ:CORT) has joined the S&P SmallCap 600, and as a result, the stocks have jumped 11%. Currently, Corcept shares are sitting at $17.59, which is up $1.79, or 11.33%, from Wednesday’s close ... [Read]